Hb Wealth Management, LLC Heron Therapeutics, Inc. Transaction History
Hb Wealth Management, LLC
- $9.29 Billion
- Q3 2024
A detailed history of Hb Wealth Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Hb Wealth Management, LLC holds 10,000 shares of HRTX stock, worth $18,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$18,000
Previous $35,000
45.71%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
196Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$48.1 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$15.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$13.7 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$12.6 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $214M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...